Skip to main content

Table 1 Detailed analysis for rs6330, genotyped in 1120 and 869 controls.

From: Genomic NGFBvariation and multiple sclerosis in a case control study

       

Genotype (%)

p value

SNP

(maj./min. allele)

cohort

Stratif-ication

Maj. allele (%)

Min. allele (%)

p value

OR (CI*1)

XX

Xx

xx

Geno-type

Major allel dominant

co-dominant

Minor allele dominant

HWE p value

N

rs6330 (C/T)

MS

Ø

1235 (57.2)

923 (42.8)

0.0038

1.210

(1.063–1.377)

356 (33.0)

523 (48.5)

200 (18.5)

0.0126

0.0579

0.3034

0.0056

0.75

1079

  

male

438 (59.8)

294 (40.2)

0.0087

1.308

(1.070–1.599)

133 (36.3)

172 (47.0)

61 (16.7)

0.0247

0.1109

0.2403

0.0091

0.67

366

  

female

797 (55.9)

629 (44.1)

0.0598

1.149

(0.946–1.395)

223 (31.3)

351 (49.2)

139 (19.5)

0.1672

0.1665

0.6840

0.0938

0.97

713

  

rr Ø

677 (56.9)

513 (43.1)

0.0211

1.193

(1.015–1.210)

192 (32.3)

293 (49.2)

110 (18.5)

0.0647

0.1011

0.5493

0.0345

0.92

595

  

rr male

240 (61.2)

152 (38.8)

0.0087

1.386

(1.086–1.770)

75 (38.3)

90 (45.9)

31 (15.8)

0.0230

0.1196

0.2226

0.0081

0.65

196

  

rr female

437 (54.8)

361 (45.2)

0.2276

1.098

(0.885–1.361)

117 (29.3)

203 (50.9)

79 (19.8)

0.4648

0.2701

0.9151

0.3737

0.59

399

  

sp Ø

271 (56.5)

209 (43.5)

0.1276

1.173

(0.955–1.439)

78 (32.5)

115 (47.9)

47 (19.6)

0.2503

0.4119

0.4231

0.1016

0.69

240

  

sp male

73 (55.3)

59 (44.7)

0.6597

1.086

(0.752–1.569)

21 (31.8)

31 (47.0)

14 (21.2)

0.7583

0.9914

0.5229

0.4839

0.69

66

  

sp female

198 (56.9)

150 (43.1)

0.1082

1.197

(0.915–1.565)

57 (32.8)

84 (48.3)

33 (19.0)

0.2593

0.2818

0.6243

0.1264

0.84

174

  

pp Ø

287 (58.8)

201 (41.2)

0.0143

1.291

(1.052–1.584)

86 (35.2)

115 (47.1)

43 (17.6)

0.0369

0.1358

0.3070

0.0137

0.67

244

  

pp male

125 (60.1)

83 (39.9)

0.0759

1.322

(0.971–1.800)

37 (35.6)

51 (49.0)

16 (15.4)

0.1967

0.1883

0.6930

0.1116

0.82

104

  

pp female

162 (57.9)

118 (42.1)

0.0779

1.245

(0.933–1.660)

49 (35.0)

64 (45.7)

27 (19.3)

0.1540

0.3615

0.3297

0.0557

0.46

140

 

control

Ø

857 (52.5)

775 (47.5)

  

221 (27.1)

415 (50.9)

180 (22.1)

    

0.57

816

  

male

443 (53.2)

389 (46.8)

  

115 (27.6)

213 (51.2)

88 (21.2)

    

0.56

416

  

female

414 (51.7)

386 (48.3)

  

106 (26.5)

202 (50.5)

92 (23.0)

    

0.82

400

  1. Significance threshold: p = 0.025 (Bonferroni corrected for 2 SNPs). Significant values indicated by bold letter;
  2. 1CI = 95%. HWE: Hardy-Weinberg equilibrium, Pearson's goodness-of-fit chi-square (degree of freedom = 1).